You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ALK-positive unresectable advanced and/or recurrent non-small cell lung cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced NSCLC Trial in India (Lorlatinib)

Completed
  • Advanced Non-Small Cell Lung Cancer
  • New Delhi, Delhi, India
  • +11 more
Sep 13, 2022

ALK Positive NSCLC Trial in Guangzhou (Loratinib)

Recruiting
  • ALK Positive Non-small Cell Lung Cancer
  • Guangzhou, Guangdong, China
    Guangdong Provincial Perople's Hospital
Oct 19, 2023

NSCLC(NSCLC) Trial in Jinan (WX-0593 Tablets)

Not yet recruiting
  • Non-Small Cell Lung Cancer(NSCLC)
  • WX-0593 Tablets
  • Jinan, Shandong, China
    Shandong Cancer Hospital and Institute
Mar 1, 2023

Non Small Cell Lung Cancer Trial (TGRX-326, Crizotinib)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • (no location specified)
Oct 8, 2023

Iruplinalkib in Treatment of ALK-Positive Non-Small Cell Lung

Recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • Jinan, Shandong, China
    Shandong Cancer Hospital and Institute
Aug 8, 2023

Imfinzi/Imjudo NSCLC Japan PMS_Japan Post-Marketing Surveillance

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
    • (no location specified)
    Apr 21, 2023

    NSCLC Trial in Davis, San Francisco (Ceritinib, Trametinib)

    Terminated
    • Non-small Cell Lung Cancer
    • Davis, California
    • +1 more
    Dec 22, 2022

    Non-small-cell Lung Carcinoma Trial in Beijing (SY-3505)

    Recruiting
    • Non-small-cell Lung Carcinoma
    • Beijing, China
      Cancer Hospital, Chinese Academy of Medical Sciences
    May 11, 2023

    Lung Cancer, NSCLC Trial (Lorlatinib, Cisplatin or Carboplatin, Pemetrexed)

    Not yet recruiting
    • Lung Cancer
    • Non-small Cell Lung Cancer
    • (no location specified)
    Jul 7, 2023

    ALK-positive NSCLC Trial in Shanghai (Alkotinib Capsules)

    Recruiting
    • ALK-positive Non-small Cell Lung Cancer
    • Alkotinib Capsules
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Nov 28, 2022

    Nonsmall Cell Lung Cancer Trial in Shanghai (HS-10365 capsules)

    Recruiting
    • Nonsmall Cell Lung Cancer
    • HS-10365 capsules
    • Shanghai, Shanghai, China
      Shanghai Chest Hospital
    Nov 22, 2023

    NSCLC Trial in Shanghai (WX-0593)

    Active, not recruiting
    • Non-small Cell Lung Cancer
    • Shanghai, China
      Shanghai Jiao Tong University Chest Hospital
    Mar 24, 2023

    NSCLC Trial in Seoul (Lazertinib/Pemetrexed/Carboplatin)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • Seoul, Korea, Republic of
      Yonsei University Health System, Severance Hospital
    Mar 23, 2023

    A Real World Study of Ensartinib in Advanced ALK-positive NSCLC

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
    • +2 more
    • Beijing, Beijing, China
      Department of Respiratory and Critical Care Medicine, Peking Uni
    Aug 10, 2022

    NSCLC Stage IV, ALK Fusion Protein Expression Trial (Peptide vaccine)

    Not yet recruiting
    • NSCLC Stage IV
    • ALK Fusion Protein Expression
    • Peptide vaccine
    • (no location specified)
    Jul 21, 2023

    Locally Advanced or Metastatic NSCLC Trial (HB1801, Taxotere)

    Not yet recruiting
    • Locally Advanced or Metastatic Non-Small Cell Lung Cancer
    • (no location specified)
    May 8, 2023

    Information Available in Chinese Non-Small-cell Lung Cancer

    Not yet recruiting
    • Non-small Cell Lung Cancer (NSCLC)
    • Shanghai, Shanghai, China
      Department of Oncology, Shanghai pulmonary hospital
    Feb 1, 2023

    NSCLC Trial in Guangzhou (TGRX-326)

    Recruiting
    • Non-small Cell Lung Cancer
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Jun 29, 2022

    Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

    Not yet recruiting
    • Metastatic Lung Non-Small Cell Carcinoma
    • +2 more
    • Cetuximab
    • +2 more
    • Sacramento, California
      University of California Davis Comprehensive Cancer Center
    Oct 2, 2023

    Non Small Cell Lung Cancer, NSCLC, Lung Cancer Trial in Port Saint Lucie, Greenville (BL-B01D1)

    Recruiting
    • Non Small Cell Lung Cancer
    • +2 more
    • Port Saint Lucie, Florida
    • +1 more
    Aug 11, 2023

    Non Small Cell Lung Cancer Trial in Beijing (Ensartinib)

    Recruiting
    • Non Small Cell Lung Cancer
    • Beijing, Beijing, China
    • +1 more
    Aug 17, 2022

    Patient Journey With Advanced Lung Cancer Positive for ALK

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
      • Fortaleza, Ceará, Brazil
      • +4 more
      Sep 26, 2022

      Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (procedure, biological, drug)

      Not yet recruiting
      • Recurrent Lung Non-Small Cell Carcinoma
      • Stage IV Lung Cancer AJCC v8
      • Biospecimen Collection
      • +5 more
      • (no location specified)
      Sep 7, 2023

      NSCLC (NSCLC) Trial in Jinan (WX-0593 Tablets, chemo, Thoracic Radiation Therapy(TRT))

      Recruiting
      • Non-small Cell Lung Cancer (NSCLC)
      • WX-0593 Tablets
      • +2 more
      • Jinan, Shandong, China
        Shandong Cancer Hospital and Institute
      Apr 24, 2022

      NSCLC Trial in Tianjin (Ensartinib, Placebo)

      Recruiting
      • Non-small Cell Lung Cancer
      • Tianjin, China
        TianJin Medical University Cancer Institute & Hospital
      Jul 13, 2022